Opko Health, Inc. OPK
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -347.49% | 94.33% | 18.88% | -322.83% | -13.09% |
| Total Depreciation and Amortization | -0.06% | -2.69% | -5.48% | -6.93% | -5.89% |
| Total Amortization of Deferred Charges | -3.62% | -96.95% | -68.14% | -78.79% | -63.87% |
| Total Other Non-Cash Items | 94.02% | -165.07% | 175.84% | 92.37% | 47.34% |
| Change in Net Operating Assets | 45.85% | 77.26% | 12.36% | 28.56% | -109.29% |
| Cash from Operations | -4.81% | 47.85% | 44.12% | 41.63% | 55.05% |
| Capital Expenditure | 11.13% | 8.50% | 42.61% | 50.75% | 60.50% |
| Sale of Property, Plant, and Equipment | -80.70% | 29.82% | -50.75% | 27.40% | -6.02% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -99.57% | -100.00% |
| Cash from Investing | -94.20% | 648.20% | -104.44% | -101.76% | -21.44% |
| Total Debt Issued | 1,634.17% | -7.69% | 51.27% | -22.28% | -97.93% |
| Total Debt Repaid | 2.64% | 86.34% | 8.68% | 62.19% | 93.97% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 30.40% | 29.02% | -- | 17.96% | 35.70% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -175.61% | -- | -- | 100.00% |
| Cash from Financing | 806.32% | 83.61% | -28.22% | 54.69% | -107.86% |
| Foreign Exchange rate Adjustments | -109.81% | -109.92% | -143.03% | 103.13% | -111.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.12% | 74.96% | -769.01% | -280.56% | -62.19% |